Search the collection

6 results for Gopalakrishna,+Prashanth

Sort by:

Sort by

Limit results to:

20 per page

6 results for Gopalakrishna,+Prashanth

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses
Author / Creator:Verstovsek, Srdan ; Gotlib, Jason ; Mesa, Ruben A. ; Vannucchi, Alessandro M. ; Kiladjian, Jean-Jacques ; Cervantes, Francisco ; Harrison, Claire N. ; Paquette, Ronald ; Sun, William ; Naim, Ahmad ; Langmuir, Peter ; Dong, Tuochuan ; Gopalakrishna, Prashanth ; Gupta, Vikas
Publisher:England: BioMed Central Ltd
Journal title:Journal of hematology and oncology, 2017-09, Vol.10 (1), p.156-6, Article 156
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis
Author / Creator:Oritani, Kenji ; Okamoto, Shinichiro ; Tauchi, Tetsuzo ; Saito, Shigeki ; Ohishi, Kohshi ; Handa, Hiroshi ; Takenaka, Katsuto ; Gopalakrishna, Prashanth ; Amagasaki, Taro ; Ito, Kazuo ; Akashi, Koichi
Publisher:Tokyo: Springer Japan
Journal title:International journal of hematology, 2015-03, Vol.101 (3), p.295-304
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
Author / Creator:Ross, David M. ; Masszi, Tamas ; Gómez Casares, María Teresa ; Hellmann, Andrzej ; Stentoft, Jesper ; Conneally, Eibhlin ; Garcia-Gutierrez, Valentin ; Gattermann, Norbert ; le Coutre, Philipp D. ; Martino, Bruno ; Saussele, Susanne ; Giles, Francis J. ; Radich, Jerald P. ; Saglio, Giuseppe ; Deng, Weiping ; Krunic, Nancy ; Bédoucha, Véronique ; Gopalakrishna, Prashanth ; Hochhaus, Andreas
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.945-954
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy
Author / Creator:Vahdat, Linda T. ; Garcia, Agustin A. ; Vogel, Charles ; Pellegrino, Christine ; Lindquist, Deborah L. ; Iannotti, Nicholas ; Gopalakrishna, Prashanth ; Sparano, Joseph A.
Publisher:Boston: Springer US
Journal title:Breast cancer research and treatment, 2013-07, Vol.140 (2), p.341-351
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib
Author / Creator:Koehler, Anne ; Hubert, Karolin ; Lange, Thoralf ; Siebolts, Udo ; Wickenhauser, Claudia ; Gopalakrishna, Prashanth ; Niederwieser, Dietger ; Monecke, Astrid ; Al-Ali, Haifa Kathrin
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Annals of hematology, 2015-11, Vol.94 (11), p.1929-1930
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best availa...
Author / Creator:McMullin, Mary Frances ; Harrison, Claire N. ; Niederwieser, Dietger ; Demuynck, Hilde ; Jäkel, Nadja ; Gopalakrishna, Prashanth ; McQuitty, Mari ; Stalbovskaya, Viktoriya ; Recher, Christian ; Theunissen, Koen ; Gisslinger, Heinz ; Kiladjian, Jean-Jacques ; Al-Ali, Haifa-Kathrin
Publisher:England: BioMed Central Ltd
Journal title:Experimental hematology & oncology, 2015-09, Vol.4 (1), p.26-26, Article 26
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Export this record

Export record to excel

A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis

Export this record

Export record to excel

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Export this record

Export record to excel

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy

Export this record

Export record to excel

JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib

Export this record

Export record to excel

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best availa...

Refine your search